Efficient sterilization phthalocyanine-carboxymethyl chitosan nano material as well as preparation method and antibacterial application thereof
By bonding the carboxymethyl chitosan chain to the aminosilica phthalocyanine group to form phthalocyanine-carboxymethyl chitosan nanomaterials, the problems of biostability and low efficiency caused by the molecular aggregation of photothermal materials are solved. Efficient photodynamic and photothermal synergy are achieved, significantly improving bacterial inhibition ability and biocompatibility.
Patent Information
- Application Number
- CN202410795065.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-19
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-06-19
AI Technical Summary
Due to molecular aggregation, existing photothermal materials have poor biostability and low photothermal conversion efficiency, and cannot achieve photodynamic and photothermal synergy, cannot effectively kill bacteria, and there are problems of difficulty in bacterial positioning and tracking of therapeutic effects.
The carboxylic acid groups on the carboxymethyl chitosan chain are bonded to the amino groups on the amino silica phthalocyanine long chain to form phthalocyanine-carboxymethyl chitosan nanomaterials, ensuring that the molecular structure is not easy to aggregate and has high efficiency The photodynamic and photothermal function synergistically, and have good biocompatibility.
It has achieved excellent photothermal response and efficient bactericidal effect in near infrared, significantly improved the photothermal conversion efficiency, enhanced bacterial inhibition ability, and showed strong bactericidal effect at low concentrations, and good biocompatibility.
Smart Images

Figure CN118903409A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a high-efficiency bactericidal phthalocyanine-carboxymethyl chitosan nano material and a preparation method thereof and an antibacterial application thereof, belonging to a functional material. Background Art
[0002] The increase in bacterial resistance has made antibiotic treatment of bacterial infections a huge challenge. Phototherapy has received great attention because it has good antibacterial effects and does not cause bacteria to develop drug resistance. Photodynamic therapy and photothermal therapy are collectively referred to as phototherapy. Compared with traditional treatment methods, phototherapy has the advantages of minimal invasiveness, extremely low toxic side effects, and repeated treatment. The principle of photodynamic therapy is that under the irradiation of light, the photosensitizer obtains energy to transition from the ground state to the excited state, and produces reactive oxygen species (ROS) through intersystem crossing to achieve the effect of killing bacteria. The principle of photothermal therapy is that the molecules that transition to the excited state return to the ground state by vibrational relaxation, and the energy is released in the form of heat energy, causing local temperature rise to kill bacteria.
[0003] Phthalocyanine is a type of planar macrocyclic molecule, which has been widely used in anti-cancer research of photodynamic therapy and photothermal therapy. Compared with metal phthalocyanine, silicon phthalocyanine has better biocompatibility, and also has the advantages of long absorption wavelength and high extinction coefficient. The hexacoordination of silicon atoms allows the axial position of silicon phthalocyanine to react. Therefore, by introducing different groups at the axial position of silicon phthalocyanine, the steric hindrance of phthalocyanine is increased and its aggregation is reduced. This can overcome the quenching of fluorescence and ROS caused by the π-π stacking of metal phthalocyanine in solution, and has great application potential in phototherapy. Most of the reports so far are to introduce groups at the axial position of silicon phthalocyanine to reduce aggregation. Due to the influence of molecular structure, aggregation still occurs at high concentrations.
[0004] Carboxymethyl chitosan is a polysaccharide with a long chain structure prepared by carboxymethylation of chitosan. Due to its antibacterial and non-toxic characteristics, it is widely used in biomedicine and food factories. So far, organic photothermal materials are basically nanomaterials formed in a molecular aggregation state, which have the disadvantages of poor biological stability and low photothermal conversion efficiency. At the same time, the aggregation state causes fluorescence quenching and photodynamic performance reduction, and the effect of photodynamic and photothermal synergy cannot be achieved. In addition, it is impossible to locate bacteria and track the therapeutic effect, and the bactericidal effect is weak.
[0005] Therefore, it is of utmost importance to develop drugs that are non-aggregating, have efficient bactericidal effects, and possess good photodynamic and photothermal synergistic antibacterial effects in the near-infrared. Summary of the invention
[0006] In view of the deficiencies of the prior art, the present invention provides a highly effective bactericidal phthalocyanine-carboxymethyl chitosan nanomaterial and a preparation method thereof and an antibacterial application thereof.
[0007] The present invention bonds the carboxylic acid group on the carboxymethyl chitosan chain with the amino group on the aminosilicon phthalocyanine long chain to obtain a covalently linked phthalocyanine-carboxymethyl chitosan nanomaterial, thereby ensuring the fluorescence emission performance of silicon phthalocyanine while ensuring both excellent photodynamic and photothermal effects, good biocompatibility, and efficient bactericidal effect.
[0008] The technical solution of the present invention is as follows:
[0009] Highly effective bactericidal phthalocyanine-carboxymethyl chitosan nanomaterial, wherein the nanomaterial is obtained by bonding the carboxylic acid group on the carboxymethyl chitosan chain with the amino group on the aminosilicon phthalocyanine long chain, and has the structure described in the following formula I:
[0010]
[0011] In formula I, n=0-10, m=3-20.
[0012] According to the present invention, preferably, in Formula I, n=1-2, m=5-10.
[0013] According to the present invention, the method for preparing the above-mentioned highly effective bactericidal phthalocyanine-carboxymethyl chitosan nanomaterial comprises the following steps:
[0014] Phthalocyanine II, carboxymethyl chitosan sodium salt III, a carboxyl activator, a carboxyl condensation agent and an organic base are dissolved in a mixed solvent of deionized water and an organic solvent, and reacted under the protection of a nitrogen atmosphere to obtain a highly efficient bactericidal phthalocyanine-carboxymethyl chitosan nanomaterial;
[0015]
[0016] In the structural formula of phthalocyanine II, n is the same as that in formula I, and in the structural formula of carboxymethyl chitosan III, m is the same as that in formula I.
[0017] According to the present invention, preferably, the mass ratio of carboxymethyl chitosan sodium salt III to phthalocyanine II is 1:1-5, preferably 1:1-2.
[0018] According to the present invention, preferably, the carboxyl activator is N-hydroxysuccinimide, the mass ratio of carboxymethyl chitosan sodium salt III to the carboxyl activator is (18-22): (22-26), the carboxyl condensing agent is 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride; and the molar ratio of the carboxyl activator to the carboxyl condensing agent is 1:1.
[0019] According to the present invention, preferably, the organic base is N,N-diisopropylethylamine, and the mass ratio of N,N-diisopropylethylamine to phthalocyanine II is 5 to 10:1, preferably 5 to 7:1.
[0020] According to the present invention, preferably, the organic solvent is N,N-dimethylformamide, dimethyl sulfoxide, methanol or ethanol, and more preferably N,N-dimethylformamide.
[0021] According to the present invention, preferably, the volume ratio of deionized water to the organic solvent in the mixed solvent of deionized water and the organic solvent is 1:1 to 3, and more preferably 1:1 to 1.5.
[0022] According to the present invention, preferably, the mass ratio of the organic solvent to phthalocyanine II is 1:4-10, and more preferably 1:4-6.
[0023] According to the present invention, preferably, the reaction time is 12 to 96 hours, more preferably 18 to 24 hours.
[0024] After the reaction is completed, the product separation and purification are also included. The specific steps are as follows: the obtained reaction mixed solution is dialyzed and freeze-dried to obtain a highly effective bactericidal phthalocyanine-carboxymethyl chitosan nanomaterial.
[0025] According to the present invention, preferably, the dialysis is: using a dialysis bag with a molecular cutoff of 1000 to 10000 Da, first dialyzing with N,N-dimethylformamide for 1 to 5 days, and then dialyzing with deionized water for 1 to 5 days.
[0026] More preferably, the molecular cutoff of the dialysis bag is 2000-3000 Da, the dialysis time of N,N-dimethylformamide is 2-3 days; and the dialysis time of deionized water is 1-2 days.
[0027] According to the present invention, preferably, freeze drying is: freeze drying at a freeze drying temperature of -60°C to -40°C for 1 to 5 days.
[0028] More preferably, the freeze-drying temperature is -60°C to -50°C, and the freeze-drying time is 1 to 2 days.
[0029] Unless otherwise specified, the present invention is carried out according to conventional techniques in the art.
[0030] According to the present invention, the preparation method of phthalocyanine II is a prior art and can be prepared by referring to patent document CN111166882A. The carboxymethyl chitosan can be purchased from the market or prepared according to the prior art.
[0031] Taking a carboxymethyl chitosan monomer bonded to two aminosilicon phthalocyanines as an example, the reaction route of the present invention is as follows:
[0032]
[0033] The present invention obtains phthalocyanine-carboxymethyl chitosan composite nanomaterial by covalent bonding of organic amino silicon phthalocyanine II and carboxymethyl chitosan III. The carboxylic acid group on the carboxymethyl chitosan chain is bonded to the amino group on the amino silicon phthalocyanine long chain. Due to the presence of the carboxymethyl chitosan long chain, the molecular structure is more three-dimensional and not easy to be stacked in a plane. Even at high concentrations, the organic amino silicon phthalocyanine will not aggregate. It not only has high singlet oxygen yield and high superoxide free radical yield, but also has excellent photothermal response in the near infrared. It is a synergistic photodynamic therapy and photothermal therapy. A new type of nanomaterial with efficient bactericidal effect. Experiments have shown that compared with aminosilicon phthalocyanine II, the photodynamic effect of phthalocyanine-carboxymethyl chitosan nanomaterial is basically the same, and the photothermal conversion efficiency is significantly improved. This is because part of the energy emitted in the form of fluorescence is converted into heat energy, which improves the photothermal effect. In addition, carboxymethyl chitosan itself has a bactericidal effect and good biocompatibility. When introduced into the molecular structure, the bactericidal effect of the nanomaterial is greatly improved. It shows excellent bactericidal effect under low concentration conditions, and the bactericidal effect is significantly better than carboxymethyl chitosan and other phthalocyanine composite nanomaterials.
[0034] Based on this, the present invention provides the application of the phthalocyanine-carboxymethyl chitosan nanomaterial.
[0035] The above-mentioned phthalocyanine-carboxymethyl chitosan nanomaterial is used in the preparation of antibacterial drugs for photodynamic therapy and photothermal therapy.
[0036] An antibacterial drug composition for photodynamic therapy and photothermal therapy comprises the above-mentioned phthalocyanine-carboxymethyl chitosan nanomaterial, and pharmaceutically acceptable adjuvants and / or carriers.
[0037] The beneficial effects of the present invention are as follows:
[0038] 1. The present invention bonds the carboxylic acid group on the carboxymethyl chitosan chain with the amino group on the amino silicon phthalocyanine long chain to obtain the phthalocyanine-carboxymethyl chitosan nanomaterial. Due to the presence of the carboxymethyl chitosan long chain, the molecular structure is more three-dimensional and not easy to be stacked in a plane. Even at high concentrations, the organic amino silicon phthalocyanine will not aggregate. It not only has a high singlet oxygen yield and a high superoxide radical yield, but also has an excellent photothermal response in the near infrared and has an excellent bactericidal effect.
[0039] 2. The phthalocyanine-carboxymethyl chitosan nanomaterial of the present invention exhibited a good bacterial inhibition effect in an in vitro antibacterial experiment. After light treatment, the survival rate of bacteria was greatly reduced, and bacteria could be killed efficiently at low concentrations (see Figure 8 , Fig. 9 ), showing efficient bactericidal effect, with good application prospects, is a class of multi-functional antibacterial drugs.
[0040] 3. The present invention can improve the absorption in the near infrared region by introducing carboxymethyl chitosan into aminosilicon phthalocyanine (II) with different chain lengths, and has good photodynamic and photothermal effects and good biocompatibility. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] Figure 1 This is a UV-visible absorption spectrum of the phthalocyanine-carboxymethyl chitosan prepared in Example 1 dispersed in N,N-dimethylformamide solution, wherein the abscissa is the wavelength and the ordinate is the absorption intensity.
[0042] Figure 2 This is the fluorescence spectrum of the phthalocyanine-carboxymethyl chitosan prepared in Example 1 dispersed in N,N-dimethylformamide solution, wherein the abscissa is the wavelength and the ordinate is the fluorescence intensity.
[0043] Figure 3 It is a fluorescence lifetime spectrum of the phthalocyanine-carboxymethyl chitosan prepared in Example 1 dispersed in N,N-dimethylformamide solution (30 μg / mL), wherein the abscissa is time and the ordinate is fluorescence intensity.
[0044] Figure 4 The phthalocyanine-carboxymethyl chitosan prepared in Example 1 was dispersed in N,N-dimethylformamide solution (10 μg / mL), and DPBF was used as a quencher to measure the singlet oxygen test UV-visible spectrum, wherein the abscissa is the wavelength and the ordinate is the absorption intensity.
[0045] Figure 5 The phthalocyanine-carboxymethyl chitosan prepared in Example 1 is dispersed in an N,N-dimethylformamide solution, and DHE is used as a fluorescent probe to measure the superoxide radical test fluorescence spectrum, wherein the abscissa is the wavelength and the ordinate is the fluorescence intensity.
[0046] Figure 6 This is a temperature change curve of the phthalocyanine-carboxymethyl chitosan prepared in Example 1 dispersed in a deionized water solution under 808 nm laser irradiation, wherein the abscissa is time and the ordinate is temperature.
[0047] Figure 7 This is a photothermal response curve of the phthalocyanine-carboxymethyl chitosan prepared in Example 1 dispersed in a deionized water solution under 808 nm laser irradiation, wherein the abscissa is time and the ordinate is temperature.
[0048] Figure 8 The phthalocyanine-carboxymethyl chitosan prepared in Example 1 is dispersed in a deionized water solution, and the photodynamic therapy and photothermal therapy as well as the synergistic treatment of the two are used to treat Staphylococcus aureus. The horizontal axis is the concentration, and the vertical axis is the survival rate.
[0049] Fig. 9The phthalocyanine-carboxymethyl chitosan prepared in Example 1 is dispersed in a deionized water solution, and the photodynamic therapy and photothermal therapy as well as the synergistic treatment of the two are used to treat Escherichia coli. The horizontal axis is the concentration, and the vertical axis is the survival rate. DETAILED DESCRIPTION
[0050] The present invention is further described below with reference to specific examples and accompanying drawings, but is not limited thereto.
[0051] The raw materials used in the present invention are all commercially available analytically pure reagents.
[0052] Phthalocyanine I used in the examples can be prepared by referring to patent document CN111166882A.
[0053] Example 1
[0054] The preparation method of phthalocyanine-carboxymethyl chitosan composite nanomaterial, phthalocyanine n=1, the steps are as follows:
[0055] (1) Dissolve sodium carboxymethyl chitosan (20.4 mg) in 10 mL of deionized water, disperse by ultrasonication, and add 5 μL of concentrated hydrochloric acid to the solution to acidify -COONa to -COOH, thereby obtaining solution a;
[0056] (2) 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (38 mg), N-hydroxysuccinimide (24 mg), N,N-diisopropylethylamine (525 μL) and aminosilicon phthalocyanine (n=1, 37.5 mg) were dissolved in 10 mL of N,N-dimethylformamide to obtain solution b;
[0057] (3) Solution b was added dropwise to solution a, stirred at room temperature, and reacted for 12 h under a nitrogen atmosphere. The product was dialyzed and freeze-dried to obtain 38.1 mg of the product, including 17.7 mg of aminosilicon phthalocyanine and 20.4 mg of carboxymethyl chitosan.
[0058] The reaction scheme and product structure of this embodiment are as follows:
[0059]
[0060] Example 2
[0061] Taking aminosilicon phthalocyanine n=2 as an example
[0062] As described in Example 1, except that aminosilicon phthalocyanine (n=1, 37.5 mg) was replaced with an equal amount of aminosilicon phthalocyanine with n=2.
[0063] Example 3
[0064] As described in Example 1, except that:
[0065] Aminosilicon phthalocyanine (n=1, 37.5 mg) was replaced with 20.4 mg of aminosilicon phthalocyanine (n=1).
[0066] Experimental example
[0067] 1. UV-Vis absorption spectrum
[0068] The phthalocyanine-carboxymethyl chitosan nanomaterial prepared in Example 1 was dissolved in N,N-dimethylformamide to prepare 10 μg / mL, 20 μg / mL, 30 μg / mL, 40 μg / mL, and 50 μg / mL solutions, and their UV-visible absorption spectra were tested. The results are as follows: Figure 1 As shown, from Figure 1 It can be seen that the nanomaterial has excellent solubility and is in a monomer state, and does not aggregate even at high concentrations.
[0069] 2. Fluorescence spectrum test
[0070] The phthalocyanine-carboxymethyl chitosan nanomaterial prepared in Example 1 was dissolved in N,N-dimethylformamide to prepare 2 μg / mL, 4 μg / mL, 6 μg / mL, 8 μg / mL, and 10 μg / mL solutions, respectively, and their fluorescence emission was tested. The results are as follows: Figure 2 As shown, from Figure 2 It can be seen that the initial fluorescence emission of the nanomaterial increases with increasing concentration.
[0071] 3. Fluorescence lifetime
[0072] The phthalocyanine-carboxymethyl chitosan nanomaterial prepared in Example 1 was dissolved in N,N-dimethylformamide at a concentration of 30 μg / mL, an excitation wavelength of 455 nm, an emission wavelength of 675 nm, and a fluorescence lifetime of ns. The results are as follows: Figure 3 As shown, the average fluorescence lifetime of the nanomaterial is 5.20ns, with good luminescence efficiency.
[0073] 4. Singlet oxygen test
[0074] The ability of the phthalocyanine-carboxymethyl chitosan nanomaterial prepared in Example 1 to generate singlet oxygen was tested using 1,3-diphenylisobenzofuran as a quencher. A 150 W halogen lamp equipped with a 610 nm cut-off filter (λ>610 nm) was used as a light source.
[0075] First, prepare a 40 μM 1,3-diphenylisobenzofuran N,N-dimethylformamide solution, add the phthalocyanine-carboxymethyl chitosan nanomaterial prepared in Example 1 to the above solution to make the concentration 10 μg / mL, transfer 3 mL of the solution to a quartz cuvette, irradiate with a light source at a time interval of 5 s, and test the UV-visible spectrum of the solution. The test results are as follows: Figure 4 As shown, 10 μg / mL phthalocyanine-carboxymethyl chitosan nanomaterials have a good singlet oxygen yield.
[0076] 5. Superoxide free radical test
[0077] Prepare N,N-dimethylformamide solution containing 250μg / mL fish sperm DNA and 10μM DHE dye, add phthalocyanine-carboxymethyl chitosan nanomaterial prepared in Example 1 to the above solution to make its concentration 30μg / mL, use 150W halogen lamp equipped with 610nm cut-off filter (λ>610nm) as light source for irradiation, the irradiation time is 0 minutes, 5 minutes, 10 minutes, 20 minutes, respectively, and test the fluorescence emission intensity of the solution. The test results are as follows: Figure 5 As shown in the figure, the yield of superoxide radicals increases with the increase of irradiation time.
[0078] 6. Photothermal response effect test
[0079] The phthalocyanine-carboxymethyl chitosan nanomaterial prepared in Example 1 was dissolved in deionized water to prepare 10 μg / mL, 20 μg / mL, 30 μg / mL, 40 μg / mL, and 50 μg / mL solutions. The phthalocyanine-carboxymethyl chitosan nanomaterial was irradiated with 808 nm laser (3 W / cm 2 ) for 10 minutes. Take photos and record them every 30 seconds with an infrared thermal imager. The temperature changes tested are as follows: Figure 6 As shown, when the power density is constant, the temperature of the solution increases with the increase of concentration.
[0080] 7. Photothermal conversion efficiency test
[0081] The phthalocyanine-carboxymethyl chitosan nanomaterial prepared in Example 1 was dissolved in deionized water to prepare a 40 μg / mL solution. 3 mL of the solution was taken into a cuvette and the 808 nm (1.5 W / cm 2 ) laser irradiation for 20 minutes, followed by natural cooling for 20 minutes. The temperature was recorded every 30 seconds using an infrared thermal imager. Figure 7 shown.
[0082] According to calculation, the phthalocyanine-carboxymethyl chitosan nanomaterial of this embodiment has a very high light-to-heat conversion efficiency. Under 808nm laser irradiation, the light-to-heat conversion efficiency reaches 26.8%.
[0083] 8. Staphylococcus aureus experimental test
[0084] 100 μL of 0.85% NaCl solution containing Staphylococcus aureus was taken, and different amounts of phthalocyanine-carboxymethyl chitosan nanomaterials prepared in Example 1 were added to obtain solutions of different concentrations; the drugs were absorbed in a 37°C constant temperature incubator for 10 min, and the cells were divided into four groups. The first group was irradiated with a 660nm LED lamp (5 min) (PDT); the second group was irradiated with an 808nm (5 min, 5 W / cm 2 ) laser irradiation (PPT); the third group was first irradiated with 660nm LED light (5min), followed by 808nm (5min, 5W / cm 2 ) laser irradiation (PDT+PPT); the fourth group is the light-protected group (control). The bacteria were spread on a nutrient plate and cultured at 37°C for 24 hours, and the CFU counts were performed. The phthalocyanine-carboxymethyl chitosan nanomaterial obtained in Test Example 1 has a high killing efficiency against Staphylococcus aureus, as shown in Figure 8 ,It can be seen from the figure that with the increase of the concentration of phthalocyanine-carboxymethyl chitosan ,nanomaterials, the bactericidal rate of Staphylococcus aureus gradually increases.
[0085] 9. E. coli experimental test
[0086] 100 μL of 0.85% NaCl solution containing Escherichia coli (EC.) was taken, and different amounts of phthalocyanine-carboxymethyl chitosan nanomaterials prepared in Example 1 were added to obtain solutions of different concentrations. The drugs were absorbed in a constant temperature incubator at 37°C for 10 min and divided into four groups. The first group was irradiated with a 660nm LED light (5 min) (PDT); the second group was irradiated with an 808nm (5 min, 5 W / cm 2 ) laser irradiation (PPT); the third group was first irradiated with 660nm LED light (5min), followed by 808nm (5min, 5W / cm 2 ) laser irradiation (PDT+PPT); the fourth group is the light-protected group (control). The bacteria were spread on a nutrient plate and cultured at 37°C for 24 hours, and the CFU counts were performed. Test Example 1 The product of phthalocyanine-carboxymethyl chitosan composite nanomaterial has a high killing efficiency against Escherichia coli, see Fig. 9 ,It can be seen from the figure that with the increase of the concentration of phthalocyanine-carboxymethyl chitosan ,nanomaterials, the bactericidal rate of Escherichia coli gradually increases.
[0087] Obviously, those skilled in the art can make various changes and modifications to the composite and preparation method of the present invention, such as replacement of the long chain in aminosilicon phthalocyanine, synthesis conditions and process, without departing from the essence and scope of the present invention. In this way, all should be within the scope of protection of the present invention.
Claims
1. Highly effective bactericidal phthalocyanine-carboxymethyl chitosan nanomaterial, wherein the nanomaterial is obtained by bonding the carboxylic acid group on the carboxymethyl chitosan chain with the amino group on the aminosilicon phthalocyanine long chain, and has the structure described in the following formula I: In formula I, n=0-10, m=3-20.
2. The highly effective bactericidal phthalocyanine-carboxymethyl chitosan nanomaterial according to claim 1, characterized in that: In formula I, n=1-2, m=5-10.
3. The method for preparing the highly effective bactericidal phthalocyanine-carboxymethyl chitosan nanomaterial according to claim 1 or 2 comprises the following steps: Phthalocyanine II, carboxymethyl chitosan sodium salt III, a carboxyl activator, a carboxyl condensation agent and an organic base are dissolved in a mixed solvent of deionized water and an organic solvent, and reacted under the protection of a nitrogen atmosphere to obtain a highly efficient bactericidal phthalocyanine-carboxymethyl chitosan nanomaterial; In the structural formula of phthalocyanine II, n is the same as that in formula I, and in the structural formula of carboxymethyl chitosan III, m is the same as that in formula I.
4. The preparation method according to claim 3, characterized in that: The mass ratio of carboxymethyl chitosan sodium salt III to phthalocyanine II is 1:1-5, preferably 1:1-2.
5. The preparation method according to claim 3, characterized in that: The carboxyl activator is N-hydroxysuccinimide, the mass ratio of carboxymethyl chitosan sodium salt III to the carboxyl activator is (18-22): (22-26), the carboxyl condensing agent is 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride; and the molar ratio of the carboxyl activator to the carboxyl condensing agent is 1:
1.
6. The preparation method according to claim 3, characterized in that: The organic base is N,N-diisopropylethylamine, and the mass ratio of N,N-diisopropylethylamine to phthalocyanine II is 5 to 10:1, preferably 5 to 7:
1.
7. The preparation method according to claim 3, characterized in that: The organic solvent is N,N-dimethylformamide, dimethyl sulfoxide, methanol or ethanol, and N,N-dimethylformamide is more preferred; The volume ratio of deionized water to the organic solvent in the mixed solvent of deionized water and the organic solvent is 1:1 to 3, more preferably 1:1 to 1.
5. The mass ratio of the organic solvent to phthalocyanine II is 1:4 to 10, more preferably 1:4 to 6; The reaction time is 12 to 96 hours, more preferably 18 to 24 hours.
8. The preparation method according to claim 3, characterized in that: After the reaction is completed, the product is separated and purified, and the specific steps are as follows: dialyzing the obtained reaction mixed solution, and freeze-drying it to obtain a highly effective bactericidal phthalocyanine-carboxymethyl chitosan nanomaterial; The dialysis is as follows: using a dialysis bag with a molecular cutoff of 1000 to 10000 Da, first dialyzing with N, N-dimethylformamide for 1 to 5 days, and then dialyzing with deionized water for 1 to 5 days; Freeze drying is performed at a freeze drying temperature of -60°C to -40°C for 1 to 5 days.
9. Use of the phthalocyanine-carboxymethyl chitosan nanomaterial according to claim 1 or 2 in the preparation of antibacterial drugs for photodynamic therapy and photothermal therapy.
10. An antibacterial pharmaceutical composition for photodynamic therapy and photothermal therapy, comprising the phthalocyanine-carboxymethyl chitosan nanomaterial according to claim 1 or 2, and pharmaceutically acceptable excipients and / or carriers.
Citation Information
Patent Citations
Phthalocyanine-chitosan oligosaccharide conjugates as well as preparation method and application thereof
CN108503726A
Zinc phthalocyanine-chitosan oligosaccharide conjugate as well as preparation method and application thereof
CN109160957A
Amino silicon phthalocyanine nano-sphere, method for preparing same and application of amino silicon phthalocyanine nano-sphere
CN109793895A
Phthalocyanine-carboxymethyl chitosan conjugate, preparation method and application thereof
CN110511299A
Phthalocyanine-RGD polypeptide-graphene oxide composite nano material and preparation method and application thereof
CN111166882A
